Mentions in press and media 5
| Date | Title | Description |
| Sign up to see | Sign up to see | Sign up to see |
| Mar 28, 2019 | Precision Bio wants to show there's a better way to edit genes — and now it has $126M in IPO cash to prove it | After spending the second half of last year laying the carpet for an IPO — complete with a crossover round and a big partnership with Gilead — Precision BioSciences has raised $126 million in its public debut. The going price... |
| Apr 11, 2012 | Using DNA to silence cancer-causing genes nets ProNAi $310K | In September 2010, the company advanced PNT2258 to a phase 1 trial for safety and tolerable dosage in patients with tumors for which there are no effective treatments. Results are expected later this year followed by the initiation of the n... |
| Using DNA to silence cancer-causing genes nets ProNAi $310K | A novel targeted cancer therapy may have a place in the multibillion-dollar cancer therapeutics market if it delivers positive results in an ongoing phase 1 clinical trial and attracts enough investor interest. Using nucleic acid-based DNA-... | |
| Agritech Startup Nu Genes Raises $6 Mn To Take Seed Biz Global | Telangana-based agritech startup Nu Genes, on Monday (December 23), announced that it has raised $6 Mn from Innovation in Food and Agriculture (IFA) Fund managed by Sathguru Catalyzer Advisors. With the recently raised funds, Nu Genes will ... |